Specific recognition of p53 tetramers by peptides derived from p53 interacting proteins

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Gabizon, Ronen ^a   Brandt, Tobias ^b   Sukenik, Shahar ^a   Lahav, Noa ^a   Lebendiker, Mario ^a   Shalev, Deborah E ^a   Veprintsev, Dmitry ^b,c,d   Friedler, Assaf ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^c PAUL SCHERRER INSTITUTE   (Switzerland)

^d ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE C ALPHA; PROTEIN P53; TETRAMER; PEPTIDE FRAGMENT;

ANISOTROPY; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; EMISSION ANISOTROPY; MOLECULAR RECOGNITION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; STATIC ELECTRICITY; SURFACE CHARGE; THERMODYNAMICS; ULTRACENTRIFUGATION; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

BINDING SITES; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN KINASE C-ALPHA; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; THERMODYNAMICS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861675066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038060     Document Type: Article

References (56)

1. Takahasi K, Horiuchi M, Fujii K, Nakamura S, Noda NN, et al. (2010) Ser386 phosphorylation of transcription factor IRF-3 induces dimerization and association with CBP/p300 without overall conformational change. Genes Cells 15: 901-910.
2. Jaffe EK, (2005) Morpheeins-a new structural paradigm for allosteric regulation. Trends Biochem Sci 30: 490-497.
3. Politi L, Chiancone E, Giangiacomo L, Cervoni L, Scotto d'Abusco A, et al. (2009) pH-, temperature- and ion-dependent oligomerization of Sulfolobus solfataricus recombinant amidase: a study with site-specific mutants. Archaea 2: 221-231.
4. Hayouka Z, Rosenbluh J, Levin A, Loya S, Lebendiker M, et al. (2007) Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium. Proc Natl Acad Sci U S A 104: 8316-8321.
5. Hayouka Z, Hurevich M, Levin A, Benyamini H, Iosub A, et al. (2010) Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein. Bioorg Med Chem 18: 8388-8395.
6. Hayouka Z, Rosenbluh J, Levin A, Maes M, Loyter A, et al. (2008) Peptides derived from HIV-1 Rev inhibit HIV-1 integrase in a shiftide mechanism. Biopolymers 90: 481-487.
7. Maes M, Levin A, Hayouka Z, Shalev DE, Loyter A, et al. (2009) Peptide inhibitors of HIV-1 integrase: from mechanistic studies to improved lead compounds. Bioorg Med Chem 17: 7635-7642.
8. Hayouka Z, Levin A, Maes M, Hadas E, Shalev DE, et al. (2010) Mechanism of action of the HIV-1 integrase inhibitory peptide LEDGF 361-370. Biochem Biophys Res Commun 394: 260-265.
9. Ryan KM, Phillips AC, Vousden KH, (2001) Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 13: 332-337.
10. Vogelstein B, Lane D, Levine AJ, (2000) Surfing the p53 network. Nature 408: 307-310.
11. Michael D, Oren M, (2002) The p53 and Mdm2 families in cancer. Curr Opin Genet Dev 12: 53-59.
12. Levine AJ, (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
13. Chene P, (2001) The role of tetramerization in p53 function. Oncogene 20: 2611-2617.
14. Lee W, Harvey TS, Yin Y, Yau P, Litchfield D, et al. (1994) Solution structure of the tetrameric minimum transforming domain of p53. Nat Struct Biol 1: 877-890.
15. Jeffrey PD, Gorina S, Pavletich NP, (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267: 1498-1502.
16. Dehner A, Klein C, Hansen S, Muller L, Buchner J, et al. (2005) Cooperative binding of p53 to DNA: regulation by protein-protein interactions through a double salt bridge. Angew Chem Int Ed Engl 44: 5247-5251.
17. Weinberg RL, Veprintsev DB, Fersht AR, (2004) Cooperative binding of tetrameric p53 to DNA. J Mol Biol 341: 1145-1159.
18. Menendez D, Inga A, Resnick MA, (2009) The expanding universe of p53 targets. Nat Rev Cancer 9: 724-737.
19. Chen Y, Dey R, Chen L, (2010) Crystal Structure of the p53 Core Domain Bound to a Full Consensus Site as a Self-Assembled Tetramer. Structure 18: 246-256.
20. Stommel JM, Marchenko ND, Jimenez GS, Moll UM, Hope TJ, et al. (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. Embo J 18: 1660-1672.
21. Brandt T, Petrovich M, Joerger AC, Veprintsev DB, (2009) Conservation of DNA-binding specificity and oligomerisation properties within the p53 family. BMC Genomics 10: 628.
22. Fernandez-Fernandez MR, Rutherford TJ, Fersht AR, (2008) Members of the S100 family bind p53 in two distinct ways. Protein Sci 17: 1663-1670.
23. Fernandez-Fernandez MR, Veprintsev DB, Fersht AR, (2005) Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad Sci U S A 102: 4735-4740.
24. van Dieck J, Fernandez-Fernandez MR, Veprintsev DB, Fersht AR, (2009) Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers. J Biol Chem 284: 13804-13811.
25. Rustandi RR, Drohat AC, Baldisseri DM, Wilder PT, Weber DJ, (1998) The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53. Biochemistry 37: 1951-1960.
26. Delphin C, Huang KP, Scotto C, Chapel A, Vincon M, et al. (1997) The in vitro phosphorylation of p53 by calcium-dependent protein kinase C-characterization of a protein-kinase-C-binding site on p53. Eur J Biochem 245: 684-692.
27. Gotz C, Scholtes P, Prowald A, Schuster N, Nastainczyk W, et al. (1999) Protein kinase CK2 interacts with a multi-protein binding domain of p53. Mol Cell Biochem 191: 111-120.
28. Wagner P, Fuchs A, Gotz C, Nastainczyk W, Montenarh M, (1998) Fine mapping and regulation of the association of p53 with p34cdc2. Oncogene 16: 105-111.
29. Rajagopalan S, Jaulent AM, Wells M, Veprintsev DB, Fersht AR, (2008) 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers. Nucleic Acids Res 36: 5983-5991.
30. Andrews P, He YJ, Xiong Y, (2006) Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function. Oncogene 25: 4534-4548.
31. Kaustov L, Lukin J, Lemak A, Duan S, Ho M, et al. (2007) The conserved CPH domains of Cul7 and PARC are protein-protein interaction modules that bind the tetramerization domain of p53. J Biol Chem 282: 11300-11307.
32. Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, et al. (1998) BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16: 1713-1721.
33. Gabizon R, Mor M, Rosenberg MM, Britan L, Hayouka Z, et al. (2008) Using peptides to study the interaction between the p53 tetramerization domain and HIV-1 tat. Biopolymers 90: 105-116.
34. Dobner T, Horikoshi N, Rubenwolf S, Shenk T, (1996) Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272: 1470-1473.
35. Martinell M, Salvatella X, Fernandez-Carneado J, Gordo S, Feliz M, et al. (2006) Synthetic ligands able to interact with the p53 tetramerization domain. Towards understanding a protein surface recognition event. Chembiochem 7: 1105-1113.
36. Gordo S, Martos V, Santos E, Menendez M, Bo C, et al. (2008) Stability and structural recovery of the tetramerization domain of p53-R337H mutant induced by a designed templating ligand. Proc Natl Acad Sci U S A 105: 16426-16431.
37. Teufel DP, Freund SM, Bycroft M, Fersht AR, (2007) Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci U S A 104: 7009-7014.
38. Wadhwa R, Yaguchi T, Hasan MK, Mitsui Y, Reddel RR, et al. (2002) Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp Cell Res 274: 246-253.
39. Record MT Jr, Anderson CF, Lohman TM, (1978) Thermodynamic analysis of ion effects on the binding and conformational equilibria of proteins and nucleic acids: the roles of ion association or release, screening, and ion effects on water activity. Q Rev Biophys 11: 103-178.
40. Robinson RA, Stokes RH, (1970) Electrolyte Solutions: Courier Dover Publications.
41. Johnson CR, Morin PE, Arrowsmith CH, Freire E, (1995) Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor. Biochemistry 34: 5309-5316.
42. Natan E, Hirschberg D, Morgner N, Robinson CV, Fersht AR, (2009) Ultraslow oligomerization equilibria of p53 and its implications. Proc Natl Acad Sci U S A 106: 14327-14332.
43. Steinberg SF, (2008) Structural basis of protein kinase C isoform function. Physiol Rev 88: 1341-1378.
44. Verdaguer N, Corbalan-Garcia S, Ochoa WF, Fita I, Gomez-Fernandez JC, (1999) Ca(2+) bridges the C2 membrane-binding domain of protein kinase Calpha directly to phosphatidylserine. EMBO J 18: 6329-6338.
45. Nikolaev AY, Li M, Puskas N, Qin J, Gu W, (2003) Parc: a cytoplasmic anchor for p53. Cell 112: 29-40.
46. Oh J, Sohn DH, Ko M, Chung H, Jeon SH, et al. (2008) BAF60a interacts with p53 to recruit the SWI/SNF complex. J Biol Chem 283: 11924-11934.
47. Schneider-Merck T, Pohnke Y, Kempf R, Christian M, Brosens JJ, et al. (2006) Physical interaction and mutual transrepression between CCAAT/enhancer-binding protein beta and the p53 tumor suppressor. J Biol Chem 281: 269-278.
48. Friedler A, Veprintsev DB, Freund SM, von Glos KI, Fersht AR, (2005) Modulation of binding of DNA to the C-terminal domain of p53 by acetylation. Structure 13: 629-636.
49. Poyurovsky MV, Katz C, Laptenko O, Beckerman R, Lokshin M, et al. (2011) The C terminus of p53 binds the N-terminal domain of MDM2. Nat Struct Mol Biol 17: 982-989.
50. Neidhardt FC, Bloch PL, Smith DF, (1974) Culture medium for enterobacteria. J Bacteriol 119: 736-747.
51. Weber PJ, Bader JE, Folkers G, Beck-Sickinger AG, (1998) A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg Med Chem Lett 8: 597-600.
52. Friedler A, Veprintsev DB, Rutherford T, von Glos KI, Fersht AR, (2005) Binding of Rad51 and other peptide sequences to a promiscuous, highly electrostatic binding site in p53. J Biol Chem 280: 8051-8059.
53. Robinson RA, Stokes RH, (1959) Electrolyte Solutions. London Butterworths.
54. Veprintsev DB, Freund SM, Andreeva A, Rutledge SE, Tidow H, et al. (2006) Core domain interactions in full-length p53 in solution. Proc Natl Acad Sci U S A 103: 2115-2119.
55. Nikolova PV, Henckel J, Lane DP, Fersht AR, (1998) Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. Proc Natl Acad Sci U S A 95: 14675-14680.
56. Schuck P, (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J 78: 1606-1619.